Non-Invasive Neurofeedback Training to Alleviate Tinnitus Distress

NCT07788638 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-08-26

No results posted yet for this study

Summary

The broad goals of this project are to apply and validate the therapeutic utility of neurofeedback-guided intervention for tinnitus and its associated psychological sufferings. In this project, the investigators will evaluate whether targeted (non-auditory networks) neurofeedback-based training can restore emotional and cognitive health for individuals with bothersome tinnitus. The investigators will also link individual tinnitus scores with objective brain imaging measures before, during, and after the intervention. The investigators will accomplish these goals by using a combined brain imaging and behavioral experimental framework.

Conditions

  • Tinnitus Aggravated
  • Tinnitus
  • Tinnitus, Subjective

Interventions

BEHAVIORAL

neurofeedback-guided brain connectivity modulation

Real-time brain signal acquired through fMRI is used to measure ongoing functional connectivity of relevant brain regions (default mode network), and displayed to participants to mediate targeted regulation.

BEHAVIORAL

sham neurofeedback-guided brain connectivity modulation

Real-time brain signal acquired through fMRI on a different participant in the past is displayed to participants under this arm during feedback training.

Sponsors & Collaborators

  • Royal Royal National Institute for Deaf People (RNID)

    collaborator UNKNOWN
  • University of Illinois at Urbana-Champaign

    lead OTHER

Principal Investigators

  • Fatima T Husain, PhD · University of Illinois Urbana-Champaign

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-12
Primary Completion
2026-12-15
Completion
2027-04-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07788638 on ClinicalTrials.gov